Alerts will be sent to your verified email
Verify Email
ZYDUSLIFE
|
Zydus Lifesciences
|
Mankind Pharma
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.47 % | 20.33 % | 15.68 % |
|
5yr Avg Net Profit Margin
|
19.02 % | 17.68 % | 15.18 % |
|
Price to Book
|
4.16 | 7.25 | 3.18 |
|
P/E
|
21.8 | 54.93 | 18.81 |
|
5yr Avg Cash Conversion Cycle
|
-84.89 Days | -13.08 Days | 74.48 Days |
|
5yr Average Interest Coverage Ratio
|
30.19 | 46.07 | 35.66 |
|
5yr Avg ROCE
|
19.65 % | 25.06 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
24.4 % | 24.62 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.17 | 0.16 | 0.12 |
|
5yr CAGR Net Profit
|
16.23 % | 9.49 % | 23.71 % |
|
5yr Average Return on Assets
|
12.22 % | 14.46 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.99 % | 72.68 % | 26.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.11 % | -3.82 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.94 % | 5.51 % | -0.6 % |
|
Zydus Lifesciences
|
Mankind Pharma
|
Dr. Reddy's Lab
|
|---|